International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Azerbaijan Medical Journal Gongcheng Kexue Yu Jishu/Advanced Engineering Science Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery Interventional Pulmonology Zhenkong Kexue yu Jishu Xuebao/Journal of Vacuum Science and Technology Wuhan Ligong Daxue Xuebao (Jiaotong Kexue Yu Gongcheng Ban)/Journal of Wuhan University of Technology (Transportation Science and Engineering) Zhonghua yi shi za zhi (Beijing, China : 1980) Zhongguo Shiyou Daxue Xuebao (Ziran Kexue Ban)/Journal of China University of Petroleum (Edition of Natural Science) Tobacco Science and Technology Teikyo Medical Journal Connected Health Agricultural Mechanization in Asia, Africa and Latin America Technology Reports of Kansai University Asia Life Sciences Open Access Journals Tagliche Praxis Bulletin of National Institute of Health Sciences Journal of the Austrian Society of Agricultural Economics Azerbaijan Medical Journal Gongcheng Kexue Yu Jishu/Advanced Engineering Science

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery Interventional Pulmonology Zhenkong Kexue yu Jishu Xuebao/Journal of Vacuum Science and Technology Wuhan Ligong Daxue Xuebao (Jiaotong Kexue Yu Gongcheng Ban)/Journal of Wuhan University of Technology (Transportation Science and Engineering) Zhonghua yi shi za zhi (Beijing, China : 1980) Zhongguo Shiyou Daxue Xuebao (Ziran Kexue Ban)/Journal of China University of Petroleum (Edition of Natural Science) Tobacco Science and Technology

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-07-11-2019-26
Total View : 714

Abstract : India being home for about 45,000 various kinds of plant species and plants have been the richest source of medicines since the ancient period. Different types of natural products which are obtained from medicinal plants are gaining a lot of importance these days in medicinal studies as a result of their well known characteristic especially that they are without side effects or causes minimum side effects as compared to other allopathic medicines. These days, there is a great demand for phyto- products like drugs, nutrition supplements and health products, pharmaceuticals, creams and lotions and other types of cosmetics etc. all over the world. It is commonly found plant in India. Different parts Giloy are used to cure different types of diseases and shows important ethno botanical value. In this review, our focus is to study morphology of the Plant, chemical composition of various parts of the plant and biological significance of this plant with respect to humans and animals. It is worth looking for a product with natural value that is safer, affordable, effective, better tolerated and devoid of side effects..
Full article
International Medical Journal
Journal ID : IMJ-06-11-2019-25
Total View : 584

Abstract : Ecstasy 3, 4-Methylenedioxymethamphetamine or MDMA is a psychostimulant drug capable of inducing psychiatric disorders in animals and humans. MDMA produces short-term pleasure effects but prompts to neuropsychiatric problems in the long-term, such as anxiety. The purpose of this study was to examine the anxiolytic potential of a natural compound known as thymoquinone (TQ) in rats that were stimulated to anxiety by MDMA. The administration of TQ into MDMA-induced 5-HT depletion rats was carried out in male Sprague Dawley via 1-week treatment dividing into four groups. The administration of TQ into MDMA-induced 5-HT depletion rats was carried out in male Sprague Dawley via a1-week treatment dividing into four groups. The studied groups involved with the treatments comprise i) Control (1 mL/kg saline), ii) MDMA (20 mg/kg MDMA), iii) MDMA-TQ (20 mg/kg MDMA + 40 mg/kg TQ) and iv) TQ (40 mg/kg TQ). Anxiety test is subject to a light-dark test and social interaction test. Our results demonstrated an increase in anxiety behaviour in the MDMA group as compared to the control group. TQ prevented anxiety after undergoing a 1-week treatment in the MDMA+TQ group as compared to the untreated MDMA group. Hence, this study proposed that TQ could protect against anxiety-like behaviour upon MDMA exposure in rats..
Full article
International Medical Journal
Journal ID : IMJ-01-11-2019-24
Total View : 527

Abstract : The purpose of the present study were isolation of K. pneumoniae from clinical samples, determination of their antibiotic sensitivity against commonly prescribed antibiotics and evaluation of their ability to produce extended-spectrum beta-lactamase (ESBL), AmpC and Carbapenemase enzymes.The study was performed at the Department of Microbiology, Primeasia University, Banani, Dhaka-1213, Bangladesh. For isolation and identification of klebsiella, cultural characteristics on blood agar and MacConkey agar was observed along with different biochemical tests and the disc diffusion assay on Mueller-Hinton agar was done for determination of antibiotic sensitivity. Statistical analysis was done by employing Statistical Package for Social Science (SPSS Version 16) software. Total 120 sputum samples were collected of them 51 (42.5%) K. pneumoniae were identified. Sensitivity towards 15 differents antibiotics were determined by Kirby Bauer disc diffusion method. Third generation cephalosporin resistant bacteria were further analyzed to determine their extended-spectrum beta lactamases enzyme producing ability by double disc synergy test. AmpC and OXA-48 disc tests were used for detection of AmpC and Carbapenemase producer. Among 51 K. pneumoniae, 39 (76.5%), 31(60.8%), and 3(5.9%) were found ESBL, AmpC and Carbapenemase producer respectively. K. pneumoniae showed maximum sensitivity to Netilmicin (92.2%), Amikacin (90.1%), Meropenem (90.1%), Imipenem (88.2%), Ciprofloxacin (80.3%), L.
Full article
International Medical Journal
Journal ID : IMJ-30-10-2019-17
Total View : 773

Abstract : Abstract: There are many drivers for the emergence of antimicrobial resistance among pathogens. Misuse of antibiotics constitutes a growing global public health concern. There are many reports of outbreaks caused by bacterial strains that have acquired several mechanisms of antimicrobial drug resistance. Objectives: This study tries to assess the general public’s knowledge and opinions regarding the use of antibiotics and bacterial resistance in a rural area of Minia, Egypt. Methods: All the participants had to be older than 16 years and had to participate in the survey voluntarily. A total of 386 participants answered the questionnaire, from March 2018 to June 2018. Results: Most of the participants (82%) received antibiotics treatment with a prescription. More than half of the respondents (68.7%) discontinue their therapy after the alleviation of symptoms. Half of the participants (50%) in this study repeated the same antibiotic after having the same symptoms. The major source of antibiotic prescription was from family and friends (65.8%). The most common reason for the administration of antibiotics was sore throat (67.4%). Most of the participants (75.1%) understood that the antibodies resistance is the resistance of bodies to antibiotics and so they will no longer work as well. Most of the participants (69.9%) showed high awareness and agreement towards giving fewer antibiotics to farm animals. Conclusion: Based on the results, the authors thought that the most c.
Full article
International Medical Journal
Journal ID : IMJ-30-10-2019-15
Total View : 598

Abstract : Direct acting antiviral agents will change the shape of the future of liver diseases especially in countries where hepatitis C virus (HCV) infection is the main cause of liver pathology. Sofosbuvir, an approved DAAs, has been incorporated into several IFN-free regimen. Some clinicians observed occurrence of HCC with initiation of DAA in cirrhotic patients, so, the clinical history and data of the reported HCC-developed patients need to be analyzed carefully before any conclusive comments. Aim We evaluated the efficacy and safety and searched for development of new hepatocellular carcinoma in Egyptian cirrhotic patients with chronic hepatitis C who are treated by a sofosbuvir-based regimen. Methods Treatment-naïve or treatment-experienced patients with genotype 4 HCV (+) advanced liver disease, who had been treated with Sofosbuvir- containing regimens (n = 200) were randomly assigned to receive either 24 weeks of sofosbuvir and ribavirin daily or 12 weeks of sofosbuvir, daclatasvir and ribavirin. Results SVR12 rates were 95% (114/120) with 24 weeks of sofosbuvir and ribavirin and 97.5% (78/80) with 12 weeks of sofosbuvir, daclatasvir and ribavirin therapy. The most common adverse events in both groups were headache, insomnia, diarrhea and fatigue. No patients had adverse events leading to dose modification, interruption, or discontinuation of sofosbuvir. Hepatocellular carcinoma was detected in one patient. Conclusion sofosbuvir-containing regimen is promising and safe.
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//